Mayer Laboratories acquires Today Sponge contraceptive distribution rights

NewsGuard 100/100 Score

Mayer Laboratories, Inc., a marketer and distributor of high-quality contraceptive and other reproductive healthcare products, has announced that it has signed an agreement with Alvogen Group for the exclusive distribution rights of the Today Sponge for the United States, Europe and Canada.

For more than 20 years, Mayer Labs has marketed and distributed contraceptive and reproductive healthcare products in the United States and abroad. According to David Mayer, CEO of Mayer Labs, "we are very excited to add the Today Sponge to our portfolio of high quality reproductive products. Today Sponge has always remained popular with many consumer advantages; the recent interruption of distribution was not the result of product quality or market viability, but was due to the previous owner's overleveraged financial condition, which ultimately lead to their bankruptcy."

According to Doug Drysdale, CEO of Alvogen, "We considered several distribution partners for the Today Sponge. We selected Mayer Labs based on their expertise in this segment and their reputation as a valued and committed partner."

Originally introduced in 1983 and later acquired by Wyeth, the Today Sponge affords the freedom and flexibility of 24-hour contraceptive protection, and offers a safe and effective non-hormonal birth control alternative for millions of American women. The Today Sponge is a popular over-the-counter birth control method for women, with over 150 million sponges sold since its introduction.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Certain progestogens linked to higher brain tumor risk in women, study suggests